MicrobiomeTrials
  • Search Trials
  • Conditions
  • Learn
  • About
Data source: ClinicalTrials.gov
This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Sign up for updates
Loading filters…
Showing 278 trials for Ulcerative Colitis
IBD Strong Peer2Peer for Self-Management of Psychological DistressRecruiting
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Psychological distress (PD) as a result of inflammatory bowel disease (IBD) is prevalent and associated with worse disea…
Halifax, CanadaEst. completion Mar 2027
View Trial →
Confirmatory Clinical Study in Active Ulcerative ColitisPhase 2Recruiting
Colitis, Ulcerative
The main goal of the study is to check if MH002 works and is safe to use. In a previous study in 45 patients with Ulcera…
Miami, United StatesEst. completion Sep 2027
View Trial →
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative ColitisPhase 1Recruiting
Ulcerative Colitis (UC)
A study to investigate the safety, tolerability, and pharmacokinetics (PK) of ONO-6414 orally in healthy adult participa…
Miami, United StatesEst. completion Dec 31, 2027
View Trial →
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)Phase 2Recruiting
Colitis UlcerativeUlcerative Colitis
The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active u…
Anaheim, United StatesEst. completion Oct 28, 2027
View Trial →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)Phase 3Recruiting
Crohn DiseaseColitis, Ulcerative
Researchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medic…
Bristol, United StatesEst. completion Dec 17, 2037
View Trial →
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:Phase 2Recruiting
Ulcerative Colitis
The main purpose of the study is to evaluate the effectiveness and safety of LY4268989 when given with mirikizumab compa…
Scottsdale, United StatesEst. completion May 2027
View Trial →
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative ColitisPhase 3Recruiting
Moderately to Severely Active Ulcerative Colitis
This Phase III, randomized, double-blind, multicenter, induction and maintenance study will evaluate the safety and effi…
Aurora, United StatesEst. completion Mar 31, 2030
View Trial →
LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisPhase 2Recruiting
Ulcerative Colitis (UC)Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
The main purpose of this study is to evaluate the safety and effectiveness of LY4268989 when compared to placebo in adul…
Phoenix, United StatesEst. completion Jun 2030
View Trial →
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's DiseasePhase 2Recruiting
Colitis, UlcerativeCrohn Disease
Study IIBD is a master protocol that will support a collection of individual sub studies that share key design component…
Scottsdale, United StatesEst. completion Jun 2027
View Trial →
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyPhase 3Recruiting
Ulcerative ColitisObesity or Overweight
The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide,…
Dothan, United StatesEst. completion Apr 2028
View Trial →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative ColitisPhase 3Recruiting
Ulcerative Colitis
Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of…
Phoenix, United StatesEst. completion Jul 2034
View Trial →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative ColitisPhase 2Recruiting
Crohn's DiseaseUlcerative Colitis
Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, se…
Dothan, United StatesEst. completion Oct 2031
View Trial →
Immune Regulation in Ulcerative Colitis or Crohn s DiseaseRecruiting
Inflammatory Bowel DiseaseUlcerative ColitisChrohn's Disease
This study will investigate in patients with Crohn s disease and ulcerative colitis how the body s immune system control…
Bethesda, United States
View Trial →
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)Recruiting
Inflammatory Bowel Disease (IBD)Crohn Disease (CD)Ulcerative Colitis (UC)IBD-unclassified (IBD-U)
The SHIFT-IBD Study is being conducted at multiple medical centers across Canada to evaluate how well guselkumab (Tremfy…
Calgary, CanadaEst. completion Nov 1, 2027
View Trial →
A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in GermanyRecruiting
Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease
The purpose of this study is to characterize participants with Crohn's Disease (CD) and Ulcerative Colitis (UC) treated …
Berlin, GermanyEst. completion Jan 15, 2029
View Trial →
Familial Inflammatory Bowel Disease Early RiskRecruiting
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)Crohn Disease (CD)Ulcerative Colitis (UC)
Brief Summary The aim of the FIBER study is to identify potential triggers associated with the later development of IBD…
Seattle, United StatesEst. completion Feb 2036
View Trial →
Piloting an Insomnia Treatment in Patients With Ulcerative ColitisRecruiting
InsomniaUlcerative Colitis
The goal of this clinical trial is to learn if telehealth-based Cognitive Behavioral Therapy for Insomnia (CBT-I) adapte…
Lebanon, United StatesEst. completion Dec 1, 2026
View Trial →
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative ColitisPhase 3Recruiting
Colitis, Ulcerative
The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinr…
Chandler, United StatesEst. completion Jan 14, 2028
View Trial →
A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA TherapeuticallyPhase 4Recruiting
PsoriasisColitis, UlcerativeCrohn DiseaseArthritis, Psoriatic
The purpose of this post-marketing study is to assess the amount of guselkumab in breast milk of lactating women receivi…
Chapel Hill, United StatesEst. completion Aug 31, 2027
View Trial →
A Long-term Extension (LTE) Study of Guselkumab in Pediatric ParticipantsPhase 3Recruiting
Crohns DiseaseColitis, UlcerativeArthritis, PsoriaticArthritis, Juvenile
The purpose of this study is to evaluate long-term safety of subcutaneous guselkumab in pediatric participants with mode…
Atlanta, United StatesEst. completion Dec 12, 2031
View Trial →
← PreviousPage 1 of 14Next →
Recruitment Status